Brian Robinson is a counsel in the firm’s Intellectual Property Litigation Group and focuses his practice on the resolution of complex intellectual property disputes. Mr. Robinson has extensive experience litigating intellectual property matters involving pharmaceutical products, and has particular expertise in patent challenges under the Hatch-Waxman Act. Mr. Robinson has handled all aspects of patent and trade secret litigation, including the development of case strategies, fact and expert discovery, motion practice, trial and appeals. In addition to his litigation practice, Mr. Robinson has substantial experience preparing and prosecuting U.S. and international patent applications in the pharmaceutical, chemical, medical device, and mechanical fields. He also has experience preparing opinions and providing counseling on patentability, infringement and validity issues.

 

Experience

Erfahrung

工作经历

Mr. Robinson’s recent work includes representing:

  • Watson in litigation involving patents listed in the Orange Book for BRILINTA® (ticagrelor). AstraZeneca v. Watson (D. Del.).
  • Sun in litigation involving patents listed in the Orange Book for BOSULIF® (bosutinib). Wyeth v. Sun (D. Del.).
  • Sun in litigation involving patents listed in the Orange Book for XELJANZ® XR (tofacitinib citrate). Pfizer v. Sun (D. Del.).
  • Sun in litigation involving patents listed in the Orange Book for ORACEA® (doxycycline). Galderma/TCD Royalty v. Sun (D. Del.).
  • Teva in litigation involving patents listed in the Orange Book for COPAXONE® 40 mg/mL (glatiramer acetate). In re Copaxone 40 mg (D. Del.).
  • Taro in litigation involving patents listed in the Orange Book for NAFTIN® Gel, 2% (naftifine hydrochloride). Sebela v. Taro (S.D.N.Y.).
  • Actavis in litigation involving patents listed in the Orange Book for XIFAXAN® (rifaximin). Salix v. Actavis (D. Del.).
  • Teva in litigation involving patents listed in the Orange Book for OPANA ER® (oxymorphone hydrochloride). Endo v. Teva (S.D.N.Y. and D. Del.).
  • Watson in litigation involving patents listed in the Orange Book for STAXYN® (vardenafil hydrochloride). Bayer v. Watson (D. Del.).
  • Ranbaxy in litigation involving patents listed in the Orange Book for OXECTA® (oxycodone hydrochloride). Acura v. Ranbaxy (D. Del.).
  • Watson in litigation involving patents listed in the Orange Book for OXYCONTIN® (oxycodone hydrochloride). Purdue v. Watson (S.D.N.Y.).
  • Zydus Noveltech in trade secret and contract litigation involving transdermal patch products. Mylan v. Zydus Noveltech (Vt. Super.).
  • Watson in litigation involving patents listed in the Orange Book for SANCTURA XR® (trospium chloride). District court invalidated patents for obviousness and affirmed by Federal Circuit on appeal. Allergan v. Watson (D. Del.).
  • Darnel Packaging in litigation involving patents related to food service packaging products. Genpak v. Darnel Packaging (N.D.N.Y.).
  • Teva in litigation involving patent listed in the Orange Book for STRATTERA® (atomoxetine hydrochloride). Eli Lilly v. Teva (D.N.J.).

Mr. Robinson maintains an active pro bono practice. He is currently working on a matter referred by Kids In Need of Defense (KIND), one of the leading organizations for the protection of unaccompanied children who enter the U.S. immigration system, involving a child from El Salvador who is facing removal proceedings in U.S. Immigration Court, and pursuing administrative relief in Family Court and through the U.S. Citizenship and Immigration Services.

Professional Activities

Mr. Robinson is a member of the New York Intellectual Property Law Association and the American Intellectual Property Law Association.

Professional Experience

Prior to joining Goodwin in 2014, Mr. Robinson was an associate at Kenyon & Kenyon where his practice focused on patent and trade secret litigation. Before that, Mr. Robinson was an associate at Ohlandt, Greeley, Ruggiero & Perle where his practice focused on patent prosecution.

Credentials

Anmeldeinformationen

专业资格

Education

J.D., 2006
New York Law School
B.S., Chemical Engineering, 2002
The Pennsylvania State University

Admissions

Bar

New Jersey
New York
U.S. Patent and Trademark Office (USPTO)

Courts

U.S. Court of Appeals for the Federal Circuit
U.S. District Court for the Southern District of New York
U.S. District Court for the Northern District of New York
U.S. District Court of New Jersey
Get In Touch
In Kontakt kommen
Get In Touch
联系我们
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Search Other Lawyers
Suche Andere Rechtsanwälte
搜寻其他律师